187
2
13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1875 | CDK2 | ||
CDK2, a eukaryotic S/T protein kinase family member, catalyzes the phosphoryl transfer from ATP γ-phosphate to the hydroxyl of serine or threonine (denoted as S0/T0) in a protein substrate. | |||
T36933 | Cdk2 Inhibitor II | Cdk2 Inhibitor II,CDK2-IN-3 | CDK |
Cdk2 Inhibitor II is a selective and potent CDK2 inhibitor50 at 60 nM. | |||
T14916 | CDK2-IN-4 | CDK | |
CDK2-IN-4 is a potent and selective inhibitor of CDK2 with an IC50 of 44 nM for CDK2/cyclin A. It shows 2,000-fold selectivity over CDK1/cyclin B with IC50 of 86 uM. | |||
TP1875L | CDK2 acetate(255064-79-0 free base) | Others | |
CDK2 acetate is a member of the eukaryotic S/T protein kinase family and its function is to catalyze the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/T0) in a protein substrate. | |||
T40160 | CDK2-IN-7 | CDK2-IN-7 | |
CDK2-IN-7 is a CDK2 inhibitor for treating cancer ( IC 50 < 50 nM). | |||
T35555 | GSK-3/CDK5/CDK2-IN-1 | GSK-3/CDK5/CDK2-IN-1 | |
GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1]. | |||
T3195 | CVT-313 | CVT 313,Cdk2 Inhibitor III,CVT313,NG26 | CDK |
CVT-313 (NG-26) is a potent, selective, reversible, and ATP-competitive inhibitor. | |||
T60154 | CDK2-IN-13 | ||
CDK2-IN-13 is a potent Cyclin-dependent kinase 2 (CDK2) inhibitor (IC50 value: 12 µM).CDK2-IN-13 is involved in cell cycle regulation and can arrest the cell cycle. CDK2-IN-13 prevents cell division and proliferation, in... | |||
TP2192 | Cdk2/Cyclin Inhibitory Peptide I | Others | |
Cyclin-dependent kinase 2 also known as cell division protein kinase 2. The protein encoded by this gene is a member of the cyclin-dependent kinase family of Ser/Thr protein kinases. This protein kinase is highly similar... | |||
T12552 | PROTAC CDK2/9 Degrader-1 | CDK | |
PROTAC CDK2/9 Degrader-1 is a potent CDK2 and CDK9 dual degrader(DC50 of 62 nM and 33 nM). | |||
T62038 | CDK2-IN-8 | ||
CDK2-IN-8 is a potent CDK2 inhibitor (IC50= 1.74 μM). CDK2-IN-8 exhibits antiproliferative activity. CDK2-IN-8 can be used for the research of melanoma. | |||
T62668 | CDK2-IN-12 | ||
CDK2-IN-12 (compound 10b) is a potent inhibitor of CDK2 (IC50: 11.6 μM). CDK2-IN-12 exhibits inhibition of hCA subtypes I, II, IX and XII with KI values of 3534, 638.4, 44.3 and 48.8 nM, respectively. CDK2-IN-12 shows CD... | |||
T82759 | CDK2-IN-20 | CDK | |
CDK2-IN-20 (compound 3b), a CDK2 inhibitor, exhibits cytotoxic effects on tumor cells with an IC50 ranging from 5.52-17.09 µM. It arrests the MCF-7 cell cycle at the S phase and induces apoptosis [1]. | |||
T79729 | EGFR/CDK2-IN-4 | EGFR | |
EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2. It prompts apoptosis in MCF-7 cells and causes S phase cell cycle arrest, e... | |||
T62567 | CDK2-IN-9 | ||
CDK2-IN-9 is a potent inhibitor of CDK2 (IC50: 0.63 μM) with anti-proliferative effects. CDK2-IN-9 is capable of blocking the cell cycle in S and G2/M phases and inducing apoptosis. CDK2-IN-9 has potential for melanoma r... | |||
T62337 | CDK2-IN-11 | ||
CDK2-IN-11 (compound 9d) is a potent inhibitor of CDK2 (IC50: 6.4 μM) and acts on hCA II (Ki: 23.4 nM), hCA IX (Ki: 56.3 nM) and hCA XII (Ki: 44.3 nM). CDK2-IN-11 can be used in anticancer studies. | |||
T79648 | CDK2-IN-19 | CDK | |
CDK2-IN-19 (Compound 32) is a selective, orally active inhibitor of CDK2 (K i: 0.18 nM) that exhibits anticancer activity in mice with OVCAR3 tumors [1]. | |||
T79727 | EGFR/CDK2-IN-2 | EGFR | |
EGFR/CDK2-IN-2 (compound 6a) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 values of 19.6 nM and 87.9 nM, respectively. It promotes apoptosis in MCF-7 cells and halts cell cycle progression du... | |||
T76377 | Cdk2/Cyclin Inhibitory Peptide II | ||
Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, demonstrates dose-dependent cytotoxic effects on U2OS osteosarcoma cells [1]. | |||
T72844 | EGFR/CDK2-IN-1 | ||
EGFR/CDK2-IN-1, an inhibitor of both EGFR and CDK2, demonstrates effective cytotoxicity towards MCF7 and HepG2 cells, suggesting its potential application in cancer research. | |||
T78813 | CDK2/Bcl2-IN-1 | CDK | |
CDK2/Bcl2-IN-1 (compound 1) is a saponin-based inhibitor of CDK-2 (IC50=117.6 nM) that exhibits potent cytotoxic effects on cancer cells. Additionally, it inhibits Bcl-2 and promotes apoptosis in A549 lung cancer cells [... | |||
T79728 | EGFR/CDK2-IN-3 | EGFR | |
EGFR/CDK2-IN-3 (compound 4b) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 values of 71.7 nM and 113.7 nM, respectively. It prompts apoptosis in MCF-7 cells and halts the cell cycle in the S p... | |||
T63209 | HDAC1/2 and CDK2-IN-1 | ||
HDAC1/2 and CDK2-IN-1 (compound 14d) are potent inhibitors of HDAC1, HDAC2 and CDK2 with IC50 values of 70.7, 23.1 and 0.80 μM, respectively. HDAC1/2 and CDK2-IN-1 are able to block the cell cycle and induce apoptosis. T... | |||
T2029 | Bohemine | ERK , CDK | |
Bohemine is a cyclin-dependent kinase inhibitor. | |||
T9615 | CK7 | CDK | |
CK7, a Cdk2/9 inhibitor, is instrumental in the synthesis of Nek1 inhibitors BSc5231 and BSc5367. | |||
T21588 | Olomoucine | ERK , CDK | |
Olomoucine is an ATP competitive inhibitor of Cdk2/cyclin A, Cdc2/CyclinB, CDK2/CyclinE, CDK5/p35, and ERK1/p44 MAP kinase with IC50s of 7, 7, 7, 3 and 25 µM, respectively. Olomoucine regulates cell cycle and exhibits an... | |||
T6612 | NU6027 | ATM/ATR , DNA-PK , CDK | |
NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-aminopurine-based inhibitors. | |||
T6866 | AUZ 454 | K03861 | CDK |
AUZ 454 (K03861) is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely. | |||
T7426 | ALSTERPAULLONE | Apoptosis , GSK-3 , CDK | |
Alsterpaullone is a Cyclin-Dependent Kinase Inhibitor, Mediated Toxicity in HeLa Cells Through Apoptosis-Inducing Effec | |||
T2028 | NG 52 | NG52,NG-52,Compound 52 | CDK |
NG 52 (NG-52) is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase. | |||
T4327 | Prexasertib dihydrochloride | LY2606368 (dihydrochloride),Prexasertib HCl,LY2606368 | Apoptosis , Chk , S6 Kinase |
Prexasertib dihydrochloride (LY2606368) is an ATP-competitive CHK1 inhibitor (Ki: 0.9 nmol/L). in the cell-free assay, its IC50 values are 8 nM and 9 nM for CHK2 and RSK, respectively. | |||
T4205 | AG-494 | Tyrphostin AG-494,AG 494,Tyrphostin B48 | EGFR , CDK |
AG-494 (Tyrphostin B48) is an inhibitor of epidermal growth factor receptor kinase. | |||
T7167 | Purvalanol B | NG 95 | CDK , Parasite |
Purvalanol B (NG 95) is a CDK inhibitor that inhibits Cdk2/cyclin A, Cdk2/cyclin E, Cdk5/p35, and Cdk2/cyclin B (IC50s = 6, 9, 6, and 6 nM, respectively) | |||
T4310 | Prexasertib | LY2606368 | Apoptosis , Chk |
Prexasertib (LY2606368) is an inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity. | |||
T21503 | (E/Z)-Zotiraciclib | (E/Z)-TG02,(E/Z)-SB1317 | FLT , JAK , CDK |
(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively. | |||
T8230 | PNU112455A hydrochloride | PNU 112455A | CDK |
PNU112455A hydrochloride is an ATP site competetive inhibitor of CDK2 and CDK5,binds to the ATP site of CDK2 and CDK5 with Kms of 3.6 and 3.2 μM, respectively. | |||
T6081 | Milciclib | PHA-848125 | Trk receptor , CDK , Autophagy |
Milciclib (PHA-848125) (PHA-848125) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2. | |||
T28218 | NU6102 | NU-6102,NU 6102 | CDK |
NU6102 is a selective and potent ATP-competitive CDK2 inhibitor with antitumor activity against CDK1/cyclinB, CDK2/cyclinA3, CDK1/CDK2, CDK4, DYRK1A , PDK1, and ROCKII, and it can be used to study rectal cancer. | |||
T2032 | WHI-P180 | Janex 3 | EGFR , VEGFR , c-RET , CDK |
WHI-P180 (Janex 3) is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively. | |||
TQ0053 | Fadraciclib | CYC065 | CDK |
Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM). | |||
T2059 | Purvalanol A | NG-60 | Apoptosis , CDK , Autophagy |
Purvalanol A (NG-60) is an effective and cell-permeable CDK inhibitor with IC50 of 70/4/35/850 nM for cdk2-cyclin A/B/E, and cdk4-cyclin D1, respectively. | |||
TQ0068 | NVP-LCQ195 | AT9311,LCQ-195 | CDK |
NVP-LCQ195 (LCQ-195) (AT9311) is a potent inhibitor of CDK1, CDK2, CDK3 and CDK5 (IC50: 1-42 nM). | |||
T6126 | JNJ-7706621 | JNJ 7706621 | Apoptosis , CDK , Aurora Kinase |
JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2. | |||
T10550 | Bisindolylmaleimide X hydrochloride | BIM-X hydrochloride,Ro31-8425 hydrochloride | CDK , PKC |
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective PKC inhibitor. It is also a potent CDK2 antagonist (IC50: 200 nM). | |||
T6167 | SU9516 | Apoptosis , p38 MAPK , CDK , PKC , Autophagy | |
SU9516 is a potent CDK2 inhibitor, with an IC50 of 22 nM, and also has inhibitory effects on CDK1 and CDK4, with IC50s of 40 nM and 200 nM, respectively. | |||
T4227 | SB1317 hydrochloride (1204918-72-8(free base)) | TG-02 hydrochloride | FLT , JAK , CDK |
SB1317 hydrochloride (1204918-72-8(free base)) (TG-02 hydrochloride) is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM). | |||
T15335 | FN-1501 | FLT , CDK | |
FN-1501 is a potent FLT3 and CDK inhibitor (IC50s: 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively). FN-1501 also has anticancer activity. | |||
T2247 | KenPaullone | 9-Bromopaullone,NSC-664704 | GSK-3 , CDK |
KenPaullone (9-Bromopaullone), a potent CDK1, CDK2 and CDK5 inhibitor, as new enhancer for iTreg cell differentiation. Kenpaullone promotes iTreg cell differentiation through increased and prolonged transcription of foxp... | |||
T2506 | AZD-5438 | AZD5438 | CDK |
AZD-5438 is an effective inhibitor of CDK, for CDK1(IC50=16 nM), CDK2(IC50=6 nM), CDK9(IC50=20 nM). | |||
T2095 | Seliciclib | Roscovitine,R-roscovitine,CYC202 | CDK |
Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E (IC50: 0.1 μM). It also inhibits Cdk7/cyclin H, Cdk5/p35, and Cdc2/cyclin B (IC50s: 0.49/0.16/0.65 μM). |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN1299 | Desmethylglycitein | 6,7,4'-Trihydroxyisoflavone | PI3K , CDK , PKC |
Desmethylglycitein (6,7,4'-Trihydroxyisoflavone) , is a novel inhibitor of PKCα in suppressing solar UV-induced matrix metalloproteinase 1, which has antioxidant, and anti-cancer activities. | |||
T6S1487 | Ginsenoside Rg5 | NF-κB , COX , IGF-1R | |
1. Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease. 2. Ginsenoside Rg5 suppresses LPS-induced nitric oxide (NO) production and proinflammatory TNF-α secretion. 3. Ginsenoside Rg5 can ... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04542 | CDK2 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
CDK2 is a member of the Ser/Thr protein kinase family. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent protein kinas... | |||
TMPY-02921 | CDK2AP2 Protein, Human, Recombinant (His) | Human | E. coli |
CDK2AP2 belongs to the CDK2AP family. Members of this family of proteins are cell-growth suppressors, associating with and influencing the biological activities of important cell cycle regulators in the S phase including... | |||
TMPK-00016 | Cpn10/HSPE1 Protein, Human/Mouse/Goat, Recombinant (His & Avi), Biotinylated | Human,Mouse,Goat | E. coli |
Cpn10/HSPE, a 10-kDa heat shock protein, is a novel interacting partner of NPAT. A pool of Cpn10 is colocalized with NPAT foci during G1 and S phases in nuclei.Cpn10 is important for S phase progression and cell prolifer... | |||
TMPY-03535 | Cyclin E Protein, Mouse, Recombinant (His & GST) | Mouse | Baculovirus-Insect Cells |
Cyclin E1 is a member of the highly conserved cyclin family and belongs to the E-type cyclin that functions as a regulator of S phase entry and progression in mammalian cells. Cyclin E1 serves as regulatory subunits that... | |||
TMPY-01550 | Cyclin E Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
Cyclin E1 is a member of the highly conserved cyclin family and belongs to the E-type cyclin that functions as a regulator of S phase entry and progression in mammalian cells. Cyclin E1 serves as regulatory subunits that... | |||
TMPY-02777 | Cyclin E Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells |
Cyclin E1 is a member of the highly conserved cyclin family and belongs to the E-type cyclin that functions as a regulator of S phase entry and progression in mammalian cells. Cyclin E1 serves as regulatory subunits that... | |||
TMPK-00015 | Cpn10/HSPE1 Protein, Human/Mouse/Goat, Recombinant (His & Avi) | Human,Mouse,Goat | E. coli |
Cpn10/HSPE, a 10-kDa heat shock protein, is a novel interacting partner of NPAT. A pool of Cpn10 is colocalized with NPAT foci during G1 and S phases in nuclei.Cpn10 is important for S phase progression and cell prolifer... | |||
TMPY-03599 | RPRD1B Protein, Human, Recombinant (His) | Human | HEK293 |
RPRD1B, together with RPRD1A, can accompany RNAP II from promoter regions to 3'-untranslated regions during transcription in vivo, predominantly interact with phosphorylated RNAP II, and can reduce CTD S5- and S7-phospho... | |||
TMPJ-00972 | CDKN1B Protein, Human, Recombinant (His) | Human | E. coli |
Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B) is a Kinesin-related motor protein necessary for mitotic spindle assembly and chromosome segregation. CDKN1B is expressed in all tissues with highest levels observed in skele... | |||
TMPH-02131 | SKP2 Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle pr... | |||
TMPY-02496 | Rad6/UBE2A Protein, Human, Recombinant (His) | Human | E. coli |
Ubiquitin-conjugating enzyme E2 A (also known as HHR6A or UBE2A), encoded by human DNA repair genes HHR6A, belongs to the ubiquitin-conjugating enzymes (E2 enzymes) family and is likely to be involved in postreplication ... | |||
TMPY-01401 | Cyclin A1 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
Cyclin A1 is a member of the highly conserved cyclin family that is characterized by a dramatic periodicity in protein abundance, and belongs to the A-type cyclin subfamily. The mammalian A-type cyclin family consists of... | |||
TMPH-01552 | IRF1 Protein, Human, Recombinant (GST & His) | Human | Baculovirus |
Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses. Regulates transcription of IFN and IFN-inducible genes, host response to viral and bacterial infections,... |